HOLLIDAY CHARLES O JR
Known title: DirectorCIK: 0001127289
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
HCA Q2 Earnings and Analyst Optimism Amid Valuation Concerns. HCA Healthcare reported strong Q2 earnings compared to other hospital chains, prompting TD Cowen to raise its price target to $460. While some analysts note the stock could trade at a discount following a 96% run, others argue its strong outpatient partnerships and financial health make it too healthy to downgrade. The company's solid performance continues to draw attention from major market lists and value stock screens.
Transaction History
| DE | ▲ Buy | Grant | 393 | $0 | 3/1/2023 | View on chart |
| HCA | ▲ Buy | Grant | 902 | $0 | 4/25/2022 | View on chart |
| DE | ▲ Buy | Grant | 425 | $0 | 3/2/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 16, 2026
Deere Faces Federal Scrutiny Amid Market Volatility
Deere & Company is currently under federal scrutiny, a development that has drawn significant investor attention. While one analysis suggests the stock may be undervalued following this review, the company recently experienced a larger drop than the general market. The stock is currently trading near its support level, reflecting mixed sentiment among investors.
Deere Faces Federal Scrutiny Amid Market Volatility. Deere & Company is currently under federal scrutiny, a development that has drawn significant investor attention. While one analysis suggests the stock may be undervalued following this review, the company recently experienced a larger drop than the general market. The stock is currently trading near its support level, reflecting mixed sentiment among investors.